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1 We studied the release of [3H]-dopamine and [3H]-noradrenaline (NA) from hippocampal synap-
tosomes induced by glutamate receptors and the associated Ca2" influx through Ca2" channels. The
release of tritiated neurotransmitters was studied by use of superfusion system and the intracellular free
Ca2+ concentration ([Ca2+]i) was determined by a fluorimetric assay with Indo-1 as a probe for Ca2".
2 Presynaptic glutamate receptor activation induced Ca2"-dependent release of [3H]-dopamine and
[3H]-NA from rat hippocampal synaptosomes. Thus, L-glutamate induced the release of both neuro-
transmitters in a dose-dependent manner (EC50 = 5.62 pM), and the effect of 100 )AM L-glutamate was
inhibited by 83.8% in the presence of 10 JIM 6-cyano-7-nitroquinoxaline-2,3-dioxine (CNQX), but was
not affected by I JAM (+ )-5-methyl-10,1 1-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine (MK-801).
3 Other glutamate receptor agonists also stimulated the Ca2+-dependent release of [3H]-dopamine and
[3H]-NA as follows: N-methyl-D-aspartate (NMDA), at 200 tiM, released 3.65 ± 0.23% of the total 3H
catecholamines, and this effect was inhibited by 81.2% in the presence of 1 JAM MK-801; quisqualate
(50 JM), S-x-amino-3-hydroxy-5-methyl4-isoxazolopropionic acid (AMPA) (100 jiM) or kainate
(100 gAM) released 1.57 ± 0.26%, 1.93 ± 0.17% and 2.09 ± 0.22%, of the total 3H catecholamines,
respectively.
4 The ionotropic glutamate receptor agonist, AMPA, induced an increase in the [Ca2+], which was
inhibited by 58.6% in the presence of 10 1M CNQX. In contrast, the increase in [Ca2J]i due to
stimulation by glutamate was not sensitive to CNQX or MK-801.
5 Nitrendipine, at I JAM, did not inhibit the neurotransmitter release induced by AMPA, but, both
0.5 JiM -conotoxin GVIA (w-CgTx) and 100 nM w-Aga IVA reduced catecholamine release to
49.03 ± 3.79% and 46.06 ± 10.51% of the control, respectively. In the presence of both toxins the
release was reduced to 12.58 ± 4.64% of the control.
6 The results indicate that activation of presynaptic glutamate receptors of the NMDA and non-
NMDA type induces the release of [3H]-dopamine and [H]-NA from rat hippocampal synaptosomes
and that the release induced by AMPA involves the activation of N- and P-type Ca2" channels which
allow the influx of Ca2" that triggers the 3H catecholamines release.
Keywords: Hippocampus; catecholamines release; presynaptic glutamate receptors; calcium; synaptosomes; voltage-sensitive
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Introduction
The exocytotic release of neutrotransmitters depends on the
Ca2" influx into the cell (for review see: Carvalho, 1982;
Augustine, 1987; Smith & Augustine, 1988; Knight et al.,
1989). The influx of Ca2" is mediated by Ca2" channels
activated upon excitation of the nerve terminal, providing a
mechanism for the coupling between stimulation and
neurosecretion (Tsien et al., 1988, 1991).
Voltage-sensitive Ca2" channels (VSCCs) are activated by
membrane depolarization and two groups of VSCC's can be
distinguished on the basis of the different sensitivities to
membrane depolarization. Low voltage-sensitive calcium
channels or T-Type VSCCs are transiently activated by small
decreases in membrane potential. High voltage-sensitive cal-
cium channels are VSCCs which are activated after large
depolarizations of the membrane. Three different types of
high VSCCs can be distinguished on the basis of their sen-
sitivity to specific antagonists. The L-type Ca2" channels are
a group of channels inhibited by dihydropyridines, like
nitrendipine (Tsien et al., 1991). The N-type Ca2" channels
are blocked by w-conotoxin GVIA (c-CgTx) (Kerr &
Yoshikami, 1984; Tsien et al., 1991). The P-type VSCCs are
' Author for correspondence at: Department of Zoology, University
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inhibited by the polyamine FTX (Llina&s et al., 1989) or by
the peptide w-Aga IVA (Mintz et al., 1992b) which is a
component of the venom of the funnel web spider, Agenelop-
sis asperta.
The excitatory neurotransmitter L-glutamate acts both at
the postsynaptic and presynaptic membranes by interaction
with its receptors. Glutamate receptors may be ionotropic,
allowing the influx of ions through a receptor channel
(Zorumski & Thio, 1992; Ruzicka & Jhamandas, 1993), or G
protein-coupled metabotropic receptors, which are coupled to
several second messenger systems (Schoepp & Conn, 1993).
The metabotropic receptors are coupled to phospholipase C
(Nicoletti et al., 1986; Sugiyama et al., 1987) and the
activated phospholipase C catalyzes the hydrolysis of phos-
phatidyl inositols and produces inositol phosphate which
releases Ca2+ from internal stores (Zorumski & Thio, 1992).
The metabotropic receptor is activated by ACPD and also by
quisqualate (Zorumski & Thio, 1992). The ionotropic
glutamate receptors are the N-methyl-D-aspartate (NMDA),
S-x-amino-3-hydroxy-5-methyl-4isoxazolopropionic acid
(AMPA) and kainate receptors (Zorumski & Thio, 1992;
Ruzicka & Jhamandas, 1993). The NMDA receptor is very
permeable to Ca2+ (MacDermott et al., 1986; Iino et al.,
1990), reversibly blocked by Mg2' (Nowak et al., 1984) and
potentiated by the co-agonist, glycine (Johnson & Ascher,
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1987; Kemp & Leeson, 1993). As compared to the NMDA
receptor, AMPA and kainate receptors are less permeable to
Ca2l (Iino et al., 1990; Ruzicka & Jhamandas, 1993). The
AMPA- and kainate-induced depolarization activates VSCCs
which allows the influx of Ca2", coupling the stimulation to
neurosecretion (Ruzicka & Jhamandas, 1993).
The effectiveness of the Ca2" entering the nerve terminal in
releasing of neurotransmitters, following presynaptic
glutamate receptors activation, depends on the spatial
localization of the receptors and the Ca2" channels in the
active zones (Smith & Augustine, 1988). In this work we
studied the role of presynaptic glutamate receptors of rat
hippocampal synaptosomes in inducing the release of [3H]-
dopamine and [3H]-noradrenaline ([3H]-NA) and we deter-
mined which high voltage-sensitive Ca2" channels mediate
the coupling between glutamate receptor activation and
catecholamine release in synaptosomes isolated from rat
hippocampus.
A preliminary account of this work has been presented at
the 14th International Society for Neurochemistry Meeting
(Malva et al., 1993).
Methods
Preparation ofsynaptosomes
A crude synaptosomal fraction (P2) was isolated from hip-
pocampi of two month-old male Wistar rats, essentially as
described previously (McMahon et al., 1992), with some
modifications. Hippocampi were homogenized in 9 volumes
of 0.32 M sucrose, 5 mM HEPES-Tris, pH 7.4, by using a
Thomas B homogenizer, and centrifuged at 3000 gn for
2 min. The pellet so obtained was washed by resuspension in
approximately the original volume of the sucrose solution
and centrifuged as above. The combined supernatants were
centrifuged at 14600 g.,, for 12 min, and a P2 pellet was
obtained. The whiter and loosely packed layer of the pellet,
which contains the majority of the synaptosomes, was
carefully isolated with a spatula and resuspended in 0.32 M
sucrose, 5 mM HEPES-Tris, pH 7.4, at a protein concentra-
tion of about 10 mg ml-1. Aliquots of 1 mg of protein were
diluted in 1 ml of sucrose medium and pelleted in a mic-
rofuge at 15800 ga,, for 2 min. The drained pellets were
stored on ice and used within 3 h. Protein concentration was
determined by the biuret method (Layne, 1957).
[Ca2+]i measurements
Loading of synaptosomes with Indo-1 was carried out essen-
tially as described previously (Duarte et al., 1991). Synap-
tosomes (3.5 mg ml-') were incubated with 3 gM Indo-1-
acetoxymethyl ester (Indo-l/AM) in a medium containing
(mM): NaCl 132, KCl 1, MgCl2 1.4, CaCl2 100, H3P04 1.2
fatty acid-free bovine serum albumin (BSA) 1 mg ml',
glucose 10 and HEPES-Na 10, pH 7.4, for 20 min, at 25°C,
followed by 10min at 30°C. The loading was stopped by
pelleting the synaptosomes at 15800g, for 10s, and the
supernatant, containing the nonhydrolyzed probe, was dis-
carded. The synaptosomal pellet was resuspended
(O.5 mg ml') in a medium containing (mM): NaCI 132, KCI
1, MgCl2 1, glucose 10 and HEPES-Na 10, pH 7.4, and
transferred into the cuvette. Fluorescence measurements were
carried out at 30°C during stirring, in a Spex Fluoromax
spectrofluorometer, at two emission wavelengths of 410 nm
and 485 nm with a single excitation wavelength of 335 nm,
using 5 nm slits. The maximal fluorescence ratio was
obtained upon addition of 2 ftM ionomycin, in the presence
of 1 mM CaCl2, and the minimal ratio was determined by
adding 40 fil of 0.5 M EGTA solution at pH 10. The
fluorescence intensities were converted into [Ca2+], values by
using the calibration equation for double emission
wavelength measurements and taking the dissociation con-
stant of the Indo-1/Ca2" complex at 250 nM (Grynkiewicz et
al., 1985). In all experiments, the synaptosomes were pre-
incubated for 300 s before stimulation, in the presence or in
the absence of drugs.
3H-catecholamine release by synaptosomes
The uptake and release of 3H catecholamines was performed
as follows: synaptosomes were loaded (0.75 mg ml-') with
100 nM dopamine, containing 5 gCi of [3H]-dopamine nmol-',
in Na+ medium (NaCl 132 mM, KCl 1 mM, MgCl2 1.4 mM,
H3PO4 1.2 mM, CaCl2 100IM, glucose 10 mM and HEPES-
Tris 1OmM, pH 7.4) containing nialamide 12.5 gM, ascorbic
acid 0.1% and fatty acid-free BSA 1 mg ml-'. The loading of
synaptosomes proceeded for 15 min at 30°C and was stopped
by pelleting the synaptosomes at 15800 g for 30 s. The super-
natant was discarded and the pellet resuspended in Na+
medium (1.5 mg ml-'). Samples of the synaptosomal suspen-
sion containing 0.75 mg of protein were aspirated and col-
lected onto Whatman GF/B filters mounted in a superfusion
system as described previously (Raiteri et al., 1974). Synap-
tosomes were washed for 15 min with Na+ medium contain-
ing 12.5 jAM nialamide and 0.1% ascorbic acid, at a flow rate
of 0.8 ml min-', using a peristaltic pump. By this time a
stable basal release of 3H catecholamines was obtained and
the sample collection was started. Each sample was collected
for 1 min and the total experiment proceeded for 10 min. All
drugs used were added 1 min before starting the sample
collection and the stimulation of synaptosomes was initiated
at minute 3. At the end of the experiment, all the filters
containing synaptosomes were dried and transferred into
scintillation vials. The radioactivity present in the samples
and in the filters was determined in vials after addition of a
scintillation cocktail (Universol, ICN laboratories), using a
liquid scintillation spectrometer (Packard, Tri-Carb 2000)
provided with a d.p.m. correction programme.
Some of the results are presented as 3H-catecholamines
released in percentage of the total 3H-catecholamines
accumulated. To determine the 3IJ-catecholamines effectively
released upon stimulation, the following calculations were
made: from the amount of 3H-catecholamines released in
each sample, the average value of basal release was subt-
racted. All individual values above basal release were sum-
med and the obtained value was considered as the 3H-
catecholamines released by the stimulus. The total 3H-
catecholamines accumulated was calculated as the sum of
3H-catecholamines released by stimulation of synaptosomes
and the- 3H-catecholamines still present in the filters at the
end of the experiment.
Catecholamine analysis by h.p.l.c.-e.d.
Dopamine, NA and dihydroxyphenylacetic acid (DOPAC)
content of synaptosomes was compared in untreated synap-
tosomes (endogenous catecholamines) and in synaptosomes
loaded with unlabelled dopamine in the conditions described
in the previous section for the loading with tritiated
dopamine. In both cases, 2 mg of synaptosomal protein was
pelleted in order to determine the content of catecholamines.
The obtained pellets were resuspended in 0.5 ml of a solution
consisting of 10% acetic acid and 0.4 M perchloric acid. The
samples were kept at - 20C for later high performance
liquid chromatography (h.p.l.c.) analysis (Duarte et al.,
1993).
Dopamine and DOPAC analysis was performed as follows:
the samples were injected into a 15 x 0.4cm Spherisorb
ODS-1 column with 5 gm particle size and eluted at a flow
rate of 1 ml min-' with a mobile phase consisting of 50mM
NaH2PO4, 1.24 mM heptanesulphonic acid, 0.24 mM EDTA,
10% methanol, pH 2.9. The electrochemical detector used
was an ESA model Coulochem II.
The same samples were used to quantify NA levels in
hippocampal synaptosomes by h.p.l.c. Samples were injected
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in a column Ultrasphere ODS, 4.7 x 75 mm with 3 Zm parti-
cle size. The mobile phase was 50 mM NaH2PO4, 0.02%
trichloroacetic acid and 14% acetonitrile, pH 3.5 (Levine,
1986). The flow rate of the mobile phase and the conditions
for electrochemical detection were the same used for
dopamine and DOPAC analysis.
Analysis of released [31]-NA, [3H]-dopamine and
[3H]-DOPAC by h.p.l.c.-e.d.
Hippocampal synaptosomes were loaded as described
previously in this paper, but with the following
modifications. The loading proceeded in the same Na+
medium (1 mg ml-' with 100 nM dopamine, containing
20 pCi of [3H]-dopamine nmoli'. One sample (1 min) of the
basal release and another sample during the first min of
stimulation, were collected. To each sample acetic acid (10%
final concentration) and perchloric acid (0.4 M final concent-
ration) were added, and the samples were stored at - 20°C
for latter h.p.l.c.-e.d. analysis (Duarte et al., 1993).
The samples were injected in a column Ultrasphere ODS,
4.7 x 7.5 mm with 3 gtm particle size with the same mobile
phase and flow conditions as described in the previous sec-
tion for NA quantification. The injected samples were
prepared as following: 186 pl of tritiated sample were mixed
with cold standards containing 100 pmol dopamine,
100 pmol NA and 50 pmol DOPAC, at a final volume of
200 Jil. A volume of 100 pl of this mixture was injected into
the column, using the appropriated loop. At the exit of the
analytical cell, five of each 2 min samples were collected into
scintillation vials and the radioactivity determined as
previously described. The radioactivity in each sample was
compared with the chromatogram of the cold standards (see
Figure 1).
Materials
Nitrendipine was obtained from Research Biochemical Inter-
national, Natick, U.S.A. The )-conotoxin GVIA (w-CgTx)
was from Peninsula Laboratories Inc., Belmont, CA, U.S.A.
The w-AGA IVA was from Scientific Marketing Associates,
U.K. and 6-nitro-7-cyano-quinoxaline-2,3-dione (CNQX)
was obtained from NOVO, Nordisk, Denmark. (+ )-5-
Methyl-16,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-
imine maleate (MK-801) was purchased from Merck Sharp &
Dohme Research Lab., Rahway, N.J., U.S.A. S-a-amino-3-
hydroxy-5-methyl-4-isoxazolopropionic acid (AMPA) was
obtained from Tocris Neuramin, Bristol, England. The
acetoxymethyl ester of Indo-1 (Indo-1/AM) was obtained
from Molecular Probes Inc. Eugene, OR, U.S.A. Ionomycin
and fatty acid-free bovine serum albumin (BSA) were from
Calbiochem-Boehringer Corp., San Diego, U.S.A. [7,8-3H]-
dopamine hydrochloride (40-60 Ci mmol ') was purchased
from Amersham Laboratories, Buckinghamshire, England.
All other reagents were from Sigma Chemical Co., St. Louis,
MO, U.S.A. or from Merck-Schuchard, Germany. Stock
solutions of Indo-1/AM, ionomycin, nitrendipine and CNQX
were prepared in dimethyl sulphoxide.
Other methods
mg-' protein) and small amounts of DOPAC (0.029 ± 0.027
pmol mg' protein) (Table 1). When we loaded the synap-
tosomes with exogenous dopamine, as described in Methods,
we observed that the total content of NA was not signi-
ficantly different from the content of endogenous NA
(2.91 ± 0.21 pmol mg-' protein) (P> 0.05). However, after
the loading with dopamine, the synaptosomal content of this
catecholamine increased to 4.40 ± 0.78 pmol mg-' protein.
The content of DOPAC in the synaptosomes observed after
loading with exogenous dopamine was also significantly
higher (2.28 ± 0.41 pmol mg-' protein) (Table 1) than the
content of the endogenous DOPAC in the synaptosomes.
Release of 3H-catecholamines by hippocampal
synaptosomes loaded with [3H]-dopamine
After loading the hippocampal synaptosomes with [3H]-
dopamine, we observed that the main component of the
tritium release in basal conditions was DOPAC (68.11 +
2.17% of basal release), but also some dopamine (23.13 +
1.89% of basal release) and NA (8.76 ± 0.64% of basal
release) were released in the same conditions (Figure 1).
However, after stimulation with L-glutamate, AMPA or KCI,
the amount of DOPAC released did not increase as com-
pared to basal conditions, some NA was released, and we
observed a large increase in the tritium efflux with the reten-
tion time characteristic of dopamine (Figure 1). Thus, the
increase in 3H catecholamines release due to stimulation with
100 JLM L-glutamate, 100 pM AMPA, 5 mM KCI or 30 mM
KCI was mainly due to the release of [3H]-dopamine
(68.43 ± 4.03%, 74.05 ± 2.66, 69.53 ± 4.17 and 71.35 +
3.19%, respectively of the total tritium released), but a
significant part of [3H]-NA was also released in the same
conditions (31.58 ± 4.03%, 25.95 ± 2.66%, 30.48 ± 4.17%
and 28.65 ± 3.19%, respectively). Thus, this methodology
allow us to study in the same sample the release of both NA
and dopamine induced by stimulating the glutamate recep-
tors, although the major neurotransmitter in the efflux
medium is dopamine (Figure ic).
Stimulation of3H-catecholamines releasefrom
hippocampal synaptosomes by glutamate receptors
agonists
Synaptosomes obtained from rat hippocampus released 3H-
catecholamines in response to stimulation with L-glutamate
in a dose-dependent manner (Figure 2). Superfusion with
medium containing 1 mM Ca2" released 0.658 ± 0.171%
(n = 9) of the total 3H-catecholamines accumulated. The
addition of L-glutamate released 3H-catecholamines in a
Ca2"-dependent process, with the EC50 determined as 5.6 piM
and the maximum 3H-catecholamines release of 2.17% of the
total tritium accumulated (Figure 2b). The release induced by
L-glutamate was dependent on extracellular Ca2", since we
did not observe [3H]-catecholamines release in the absence of
added Ca2" (Figure 2a).
Table 1 Catecholamine levels in synaptosomes from rat
hippocampus, determined by high performance liquid
chromatography (h.p.l.c.)
Results are presented as means ± s.e.mean of the number of
experiments indicated. Statistical significance was determined
by Student's two-tailed t test.
Results
Endogenous content ofNA, dopamine and DOPAC in
hippocampal synaptosomes
The hippocampal synaptosomes contain endogenous NA
(2.94 ± 0.22 pmol mg-' protein), dopamine (0.69 ± 0.16 pmol
A
DOPAC
NA
Dopamine
B
0.03 ± 0.03 (n = 6) 2.28 ± 0.41 (n = 6)*
2.94±0.22 (n=6) 2.91±0.21 (n=6)
0.69 ± 0.16 (n = 5) 4.40 ± 0.78 (n=5)*
A, Endogenous content of dihydroxyphenylacetic acid
(DOPAC), noradrenaline (NA) and dopamine. B Contents
of DOPAC, NA and dopamine observed after the loading
of the synaptosomes with exogenous dopamine as described
in the Methods Section. The values are expressed as
pmol mg ' protein.
*Significantly higher than endogenous, P<0.05.
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Figure 1 Release of tritiated catecholamines by hippocampal synap-
tosomes loaded with [3H]-dopamine. (a) H.p.l.c. chromatogram of
cold standards of 50 pmol of dihydroxyphenylacetic acid (DOPAC),
100 pmol noradrenaline (NA) and 100 pmol dopamine. (b) Separa-
tion of tritiated DOPAC, NA and dopamine released in basal condi-
tions by h.p.l.c. The tritiated samples were supplemented with cold
standards of DOPAC, NA and dopamine, and the 2 min samples
correspondent to each standard were collected and the radioactivity
counted. (c) Tritiated NA and dopamine released by stimulation of
synaptosomes with 1I00 JAM L-glutamate (A), 10011M AMPA (B),
5 mM KCl (C) or 30 mM KCI (D). Only NA and dopamine release
was evoked by the stimulation of the synaptosomes, whereas the
release of DOPAC was the same before or after the stimulation. The
results are the mean value ± s.emean of 4 to 8 experiments per-
formed in duplicate. For abbreviations in this and subsequent figure
legends, please see text.
We also observed that agonists of the ionotropic glutamate
receptors induced the release of 3H-catecholamines (Figures 2
and 3). Thus, the extent of tritium release by 100 lM AMPA
was 1.93 + 0.17% (n = 9) (EC50 = 10.9 iM and maximum 3H-
catecholamines release = 2.09%), and by 100 gM kainate was
2.09 ± 0.22% (n = 6) (EC~o = 4.9 lsm and maximum 3H-cate-
cholamines release = 2.22%) (Figures 2b and 3b). Quis-
qualate (50 gsM) released 1.57 ± 0.26% (n = 5) of the total 3H
accumulated. We also observed that NMDA, in the presence
of 5 gM glycine and in the absence of added Mg2", was
effective in releasing 3H-catecholamines. Thus, NMDA
(200 gM) released 3.65 ± 0.23% (n = 13) of the total 3H-
catecholamines (Figure 3).
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Figure 2 Effect of L-glutamate (Glu) on the release of 3H-
catecholamines in rat hippocampal synaptosomes. (a) Fractional
release induced by Ca2+ (I mM) alone (J), by 100 JAM L-glutamate
in medium without Ca2+ (A), or by 10 AM L-glutamate (U) in the
presence of I mm Ca2+. The results are the mean value ± s.e.mean of
4 to 9 experiments performed in duplicate. (b) Dose-response curves
for the release of 3H-catecholamines induced by L-glutamate (U),
AMPA (0) or kainate (A). The curves were determined by the
mean value ± s.e.mean of 4 to 5 independent experiments performed
in duplicate.
Glutamate-induced release of3H-catecholamines is due
to receptor activation
It has been described in various cell models that L-glutamate
increases the [Ca2+]i in part due to glutamate transport,
which can cause membrane depolarization, and activate
VSCCs (Heinonen et al., 1989; McMahon et al., 1989).
Therefore, we investigated whether the observed Ca2+-
dependent release of 3H-catecholamines induced by L-
glutamate was mediated through the L-glutamate transport
or by activation of presynaptic glutamate receptors.
We observed that the increase of the hippocampal synap-
tosomal [Ca2+]i due to 1I00 JM L-glutamate was not inhibited
by 10 IM CNQX or 1 IM MK-801 (Figure 4a). However, the
100gM AMPA-induced increase in the [Ca2+], was strongly
inhibited by 10 iM CNQX (58.6% inhibition) (P<0.05)
(Figure 4b). Interestingly, when we studied the effects of
L-glutamate or AMPA on the release of 3H-catecholamines,
we observed that the release induced by L-glutamate or by
AMPA was inhibited by CNQX (Figure 5a and b), but, in
the presence of 1 g4M MK-801, the observed release of [3H]-
catecholamines induced by 100 ILM L-glutamate was not
significantly different from the control (P>0.05), indicating
that the release evoked under these conditions did not
involve the activation of NMDA receptors. However, in the
presence of 101iM CNQX, the release induced by 10011M
L-glutamate was reduced by 83.8% (Figure 5a), indicating
10
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Figure 3 3H-catecholamine release induced by L-glutamate receptor
agonists. (a) Fractional release induced by Ca2" (1 mM) alone (-) or
by 100 gM AMPA (0), 100 M kainate (0), 501M quisqualate (0),
in the presence of 1 mm Ca2"; or 2001M NMDA in the absence of
Mg2" and in the presence of 1 mm Ca2" (A). (b) 3H-catecholamines
released by L-glutamate receptor agonists (applied from min 3 to 9)
as a percentage of the total tritium accumulated. The results are the
mean value ± s.e.mean of 5 to 13 experiments performed in dup-
licate.
activation of ionotropic non-NMDA glutamate receptors
coupled to [3H]-dopamine and [3H]-NA release. Further
evidence that presynaptic non-NMDA glutamate receptors
activation release 3H-catecholamines was obtained in a study
in which we observed that a specific non-NMDA glutamate
receptor agonist (AMPA) induced the release of 3H-
catecholamines and that this release was significantly
inhibited (P<0.05) by 10 AM CNQX (61.2% inhibition)
(Figure 5b).
As reported above, we did not observe any inhibition of
the 100lM L-glutamate induced [3H]-dopamine or [3H]-NA
release by 1 ItM MK-801 (Figure 5a). However, we observed
that 200 gM NMDA in the presence of 5 pM glycine, and in
the absence of added Mg2", induced the release of 3.65 ±
0.23% (n = 13) of the total tritiated neurotransmitter accu-
mulated (Figures 3 and 5c). The release of 3H-catecholamines
induced by NMDA was inhibited by 81.2% by 1 JiM MK-801(Figure 5c).
AMPA induced release of3H-catecholamines is mediated
by N- and P-type VSCCs
The ionotropic glutamate receptors activated by AMPA
allow the influx of cations, inducing membrane depolariza-
tion (Ruzicka & Jhamandas, 1993) which may activate
VSCCs, allowing the influx of Ca2l which may trigger the
release of several neurotransmitters. In this work we
observed that the L-type VSCCs blocker nitrendipine (Tsien
et al., 1988; 1991) did not inhibit the release of [3H]-dopa-
mine or [3H]-NA, but the N-type calcium channel blocker,
w-CgTx (Kerr & Yoshikami, 1984; Reynolds et al., 1986)
inhibited the release of [3H]-catecholamines to 49.03 ± 3.79%
of the control whereas, the w-Aga IVA, a blocker of the
P-type VSCCs (Mintz et al., 1992a,b) reduced the release of
3H-catecholamines to 46.06 ± 10.51% the control. When
both blockers were perfused simultaneously, the release of
3H-catecholamines was inhibited to 12.76 ± 4.64% (n = 4) of
the control. The release observed in the presence of w-CgTx,
in the presence of c-Aga IVA or with both toxins were
significantly different from the release observed in the
absence of VSCC blockers (P<0.05) (Figure 6).
These results suggest that most of the Ca2"-dependent
release of [3H]-dopamine and [3H]-NA, due to activation of
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presynaptic receptors with AMPA, is a consequence of acti-
vation of VSCCs due to membrane depolarization induced
by activation of the AMPA receptors (Figures 5 and 6).
Discussion
Dopaminergic and noradrenergic terminals are present in the
hippocampus (Wyss et al., 1979; Lopes da Silva et al., 1990).
It was shown previously that synaptosomes isolated'from rat
hippocampus are endowed with endogenous dopamine and
NA, and that they release catacholamines in response to
depolarization (Verhage et al., 1992). However, in spite of the
presence of dopamine in the hippocampus, the physiological
role of this neurotransmitter in this area of the brain is still
unclear (Lopes da Silva et al., 1990).
We have determined the endogenous content of NA and
dopamine in the crude synaptosomal fraction of the hippo-
campus used in this work. The NA content of these synapto-
somes is about four fold higher than the dopamine content
(Table 1), in agreement with previous observations showing
much higher levels of NA than of dopamine in purified
hippocampus synaptosomes (Verhage et al., 1992). However,
we find a dopamine content about 3.5 fold higher than that
reported (Verhage et al., 1992). We also found that the NA
content was about 18.3 fold lower than the levels described
earlier (Verhage et al., 1992). These differences are probably
due to different isolation methods used for preparing the
synaptosomes. Apparently, we used a crude synaptosomal
fraction which is much richer in dopamine and poorer in NA
than the purified synaptosomes used by Verhage et al. (1992).
We used h.p.l.c.-e.d. to analyze the nature of the 3H-
catecholamines released by hippocampal synaptosomes pre-
viously loaded with [3H]-dopamine. In the hippocampus the
catecholamine nerve terminals are less than 1I% of the total
nerve terminals (Lopes da Silva et al., 1990), and the
endogenous content of either NA or dopamine is too low to
allow the study of endogenous catecholamines release stimu-
lated by presynaptic glutamate receptors. Thus, we decided
to use [3H]-dopamine loaded synaptosomes since the high
sensitivity of the tritium detection allowed us to detect very
small amounts of neurotransmitters released.
Monoamine oxidase can transform'dopamine in DOPAC,
in an enzymatic reaction inhibited by nialamide. We observed
in our preparation that after loading the synaptosomes'with
exogenous dopamine, the synaptosomal content of DOPAC
increased (Table' 1). We concluded that, in spite of the
presence of nialamide throughout the experiment, some
dopamine was metabolized to DOPAC. In this work, we also
observed that DOPAC is released in basal conditions and
that the increase in 3H-catecholamines release observed after
synaptosomal stimulation was mainly due to the release of
dopamine and, to a smaller extent, to release of NA (Figure
1). After loading the synaptosomes with dopamine, we
observed that the NA content of hippocampal synaptosomes
did not increase (Table,1). However, we observed that after
stimulation of the synaptosomes some [3H]-NA was released,
indicating that in hippocampal synaptosomes some [3HJ-
dopamine can be transported into noradrenergic terminals
and then be converted in C3H]-NA (Figure 1).
The increase in [H]-NA release observed after [3H]-
dopamine loading and the finding that NA content of the
synaptosomes did not increase after loading with dopamine
may be explained by the rapid turnover of NA, which allows
the conversion of [3H]-dopamine in [3H]-NA without affecting
total NA levels. During the loading of hippocampal synap-
tosomes with [3H]-dopamine the neurotransmitter can be
transported into both dopaminergic and noradrenergic nerve
terminals. In the dopaminergic nerve terminals this cate-
cholamine is stored in dopaminergic synaptic vesicles (Henry
& Scherman, 1989; Moriyama et al., 1993), whereas in nor-
adrenergic terminals the (H]-dopamine is transported into
the nerve terminal and is accumulated in the noradrenergic
synaptic vesicles where it is transformed to [3HI-NA. In otherbrain regions with high ratios NA/dopamine, experimental
evidence suggested that dopamine can also be accumulated
into noradrenergic terminals and converted into NA (Kelly et
al., 1985; Carboni et al., 1990).
We observed that the majority of the 3H-catecholamines
released after stimulation of the synaptosomes with 30 mM
KCI (71.4 ± 3.2%), 5M KCI (69.5 ± 4.2%), 100AM L-gluta-
mate (68.4 ± 4.0%) or 100 gM AMPA (74.1 ± 2.7%), was in
fact [3H]-dopamine, but that a significant portion of the
3H-catecholamines was released as [3H1-NA (28.7 ± 3.2% for
30mM KCl, 30.5±3.2% for 5mM KCl, 31.6±4.0% for
1I00 JM L-glutamate and 26.0 ± 2.7% for 100 tM AMPA).
L-Glutamate induced the release of (H]-dopamine and [H]-
NA from rat hippocampal synaptosomes in a process which
depends on extracellular Ca2" (Figure 2). The dependence on
external Ca2" of the dopamine release induced by depolariza-
tion (Raiteri et al., 1978; Drapeau & Blaustein, 1983) is due
to the requirement of Ca2+ for exocytosis, since this neuro-
transmitter is stored in synaptic vesicles within the synaptic
terminal (Henry & Scherman, 1989; Moriyama et al., 1993).
The release of 3H-catecholamines induced by 100 gM L-
glutamate in the presence of 1 mM Ca2' and 1 mM Mg2" was
reduced by 83.8% by 10 gM CNQX, but it was insensitive to
I 4M MK-801 (Figure 5). The insensitivity of the L-glutamate
induced [3H]-dopamine and 3H]-NA release to the NMDA
receptor inhibitor, MK-801, probably reflects the blocking of
the NMDA receptor channel by Mg2" (Nowak et al., 1984;
Zorumski & Thio, 1992), and the depolarization which
occurs after the non-NMDA feceptors activation probably
was not sufficient to remove the Mg2e from the NMDA
receptor channel. Another possibility is the localization of the
NMDA and non-NMDA receptors in different synapto-
somes, which could explain the finding that the activation of
the non-NMDA receptors was not sufficient to release the
NMDA channel from the blockade due to Mg2".
The 1I00 JM L-glutamate induced change in [Ca2"],, which
reflects the influx of Ca2" following stimulation of synap-
tosomes, was insensitive to 10 gM CNQX or 1 gM MK-801(Figure 4). The insensitivity of the L-glutamate induced in-
crease in the [Ca2+]i to the non-NMDA glutamate receptor
antagonist, CNQX (Honore et al., 1988; Zorumski & Thio,
1992; Fligure 4a), or to the NMDA glutamate receptor antag-
onist, MK-801 (Zorumski & Thio, 1992; Figure 4a) is com-
patible with the idea that L-glutamate traosport through its
carrier may lead to Ca2" influx due to. depolarization which
activates VSCCs. These results are in agreement with pre-
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vious observations that D-aspartate increases the [Ca2;- in
synaptosomes from the guinea-pig cerebral cortices (Mc-
Mahon et al., 1989). However, the release of 3H-catechol-
amines induced by glutamate does not appear to be mediated
by a carrier-dependent process, since it is sensitive to CNQX.
This observation indicates that presynaptic non-NMDA glut-
amate receptors mediate the release of 3H-catecholamines in
this preparation. We also observed that both NMDA and
non-NMDA glutamate receptor agonists induced the release
of 3H-catecholamines (Figure 3). The release induced by
100 gM AMPA was sensitive to 10 gM CNQX and the release
induced by 200 JAM NMDA was inhibited by 1 gM MK-801
(Figure 5). These results are consistent with both presynaptic
non-NMDA and NMDA receptor activation mediating the
Ca2+-dependent 3H-catecholamine release.
Interestingly, NMDA (200tJM) is the glutamate receptor
agonist which induces the highest release of 3H-cate-
cholamines (Figure 3). This result apparently is contradictory
to the observation that NMDA is the least effective gluta-
mate receptor agonist in elevating the [Ca2+], (not shown).
Probably, the local Ca2+ concentrations attained in the active
zones (Smith & Augustine, 1988) after the NMDA receptors
activation are sufficient to induce 3H-catecholamine release,
without changing the bulk Ca2+ concentrations to any great
extent. Another possible explanation is that only a sub-
population of synaptosomes respond to NMDA stimulation,
inducing a large efflux of 3H-catecholamines, without causing
large average changes in the [Ca2+], of all the synaptosomes.
Glutamate receptors modulate the release of several
neurotransmitters and neuromodulators (Ruzicka & Jhaman-
das, 1993). The ionotropic NMDA receptor stimulation was
reported to induce the release of NA from rat hyppothalamus
slices, but had no effect on the release of dopamine in this
preparation (Blandina et al., 1992). The presence of
presynaptic NMDA receptors able to induce the release of
NA was also demonstrated in synaptosomes isolated from rat
cerebral cortex (Fink et al., 1990). In the hippocampus, the
presence of presynaptic glutamate receptors which modulate
the release of NA was shown for both NMDA receptors
(Pittaluga & Raiteri, 1990; Wang et al., 1992) and non-
NMDA receptors (Pittaluga & Raiteri, 1992; Wang et al.,
1992). Glutamate receptors also modulate the release of
dopamine in rat mesencephalic cells in culture by both
NMDA and non-NMDA subtypes (Mount et al., 1990).
Presynaptic glutamate receptors activated by kainate (Desce
et al., 1991; Wang, 1991), by AMPA (Desce et al., 1991;
Wang et al., 1991; Desce et al., 1992) or by NMDA (Krebs et
al., 1991; Wang, 1991; Desce et al., 1992) also modulate the
release of dopamine from synaptosomes isolated from the rat
striatum.
The present work specifically addressed the mechanisms
involved in the coupling between presynaptic glutamate
receptor activation and catecholamine release. We showed
that after stimulating hippocampal synaptosomes with
glutamate or AMPA, an increase in the [CaJ2+J was observed
(Figure 4), due to presynaptic glutamate receptors stimula-
tion. We further characterized the involvement of VSCCs in
the Ca2+ influx coupled to dopamine and NA release. Thus,
we observed that, nitrendipine, which blocks the L-type
VSCCs (Tsien et al., 1988; 1991) did not affect the AMPA
induced catecholamines release (Figure 6), indicating that
L-type calcium channels do not mediate the influx of Ca2+
following AMPA receptor activation. It was previously
observed that 1 JAM nitrendipine does not inhibit significantly
the release of dopamine from cultured foetal rat ventral
mesencephalon evoked by glutamate receptor agonists
(Chadieu et al., 1992), also indicating that the L-type VSCCs
are not activated following glutamate receptor activation.
However, it was observed in the same work that the activa-
tion of the L-type calcium channels by Bay K 8644 induces
the release of [3H]-dopamine and that this activation could be
blocked by nitrendipine (Chadieu et al., 1992).
The N-type calcium channels blocker, w-CgTx (Kerr &
Yoshikami, 1984; Reynolds et al., 1986), strongly inhibited
the 100 IJM AMPA induced release of 3H-catecholamines
(Figure 6), and the same extent of inhibition by w-CgTx was
also observed on the elevation of the [Ca2J]i induced by
AMPA (not shown), indicating that the N-type VSCCs are
important in mediating the effects between AMPA receptor
activation and neurotransmitter release. It was shown
previously that w-CgTx inhibits the release of noradrenaline
and 5-hydroxytryptamine, as well as the Ca2" influx, in
synaptosomes isolated from rat hippocampus or striatum
(Reynolds et al., 1986). Furthermore, the ability of w-CgTx
in inhibiting the KC1 evoked release of NA and dopamine as
well as the influx of Ca2", was shown to depend on stimulus
intensity (Keith et al., 1993; Turner et al., 1993).
A dihydropyridine and w-CgTx insensitive class of VSCCs,
which is inhibited by FTX (Llinas et al., 1989) and by t-Aga
IVA (Mintz et al., 1992a,b) the P-type calcium channels, have
been shown to be particularly important in mammalian nerve
terminals (Mintz et al., 1992a,b; Turner et al., 1992; 1993;
Tareilus et al., 1993). We observed in the present study that
the 3H-catecholamines release induced by AMPA was also
strongly inhibited by w-Aga IVA (Figure 6). This observation
indicates that P-type VSCCs are important in mediating the
influx of Ca2" following AMPA receptor activation, which
induced the release of 3H-catecholamines. We observed that
w-Aga IVA also inhibited the AMPA-induced increase in the
[Ca2+]i as well as the KCl induced increase in the [Ca2J]i (not
shown). When we applied w-CgTx and o-Aga IVA simul-
taneously, we observed that the inhibition of 3H-
catecholamine release was almost complete, supporting the
idea that the influx of Ca2" following AMPA receptor
stimulation occurred mainly through N- and P-type VSCCs.
Other authors have reported effects of co-Aga IVA on 45Ca2"
influx into synaptosomes (Mintz et al., 1992b; Tareilus et al.,
1993). The release of glutamate by rat cortical or striatal
synaptosomes is also sensitive to c-Aga IVA (Turner et al.,
1992; 1993), also indicating the presence of P-type VSCCs in
glutamatergic terminals. The release of dopamine in rat
striatal synaptosomes induced by depolarization with KC1 or
4-aminopyridine is inhibited by blockers of the P-type
VSCCs (Turner et al., 1993). A synergistic inhibition of KC1
evoked (3HJ-dopamine release was observed by combining the
effects of w-Aga IVA and w-CgTx, suggesting the coexistence
of P- and N-type calcium channels in dopaminergic terminals
of the striatum (Turner et al., 1993).
In summary, we showed here that presynaptic glutamate
receptors modulate the release of [3H]-dopamine and [3H]-NA
in rat hippocampal synaptosomes, since glutamate receptors
agonists were effective in releasing these catecholamines in a
Ca2"-dependent manner. The AMPA induced release of 3H-
catecholamines is mediated by VSCC activation of the N-
and P-type, which allows the influx of Ca2" and therefore the
exocytosis of synaptic vesicles. These observations are in
agreement with the current idea that the function of the
N-type calcium channels can be closely related to the release
of catecholamines (Reynolds et al., 1986; Tsien et al., 1988),
and with the coexistence of both N- and P-type VSCCs in
dopaminergic terminals (Turner et al., 1993).
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